OneSource Specialty Pharma Ltd. NSE: ONESOURCE | BSE: 544292

OneSource Specialty Pharma Live Share Price Today, Share Analysis and Chart

Name: OneSource Specialty Pharma Ltd.: Is Infosys Ltd. worth buying?
Item: OneSource Specialty Pharma Ltd.
Rating: 1.969916625
Author: Trendlyne DVM scores

Expensive Performer

about

OneSource Specialty Pharma is engaged in the research, development, manufacture and commercialisation of biological drug products in various injectable formats. OneSource also offers end-to-end Contract Development and Manufacturing Operations servic...

1657.60 -8.90 (-0.53%)

26.26% Fall from 52W High

367.8K

NSE+BSE Volume

NSE 09 Dec, 2025 3:31 PM (IST)

Loading... You have run out of DVM views! Check usage

Subscribe now to see details

Medium Financial Strength

- / 100

Expensive Valuation

- / 100

Technically Neutral

41.3 / 100

Expensive Performer These stocks are with medium quality and mid-range technical aspects. However, their financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM

2,531

1Yr Price target upside is 53%

4 analysts

OneSource Specialty Pharma Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

OneSource Specialty Pharma Live Share Price Today, Share Analysis and Chart

OneSource Specialty Pharma is engaged in the research, development, manufacture and commercialisation of biological drug products in various injectable formats. OneSource also offers end-to-end Contract Development and Manufacturing Operations servic...

26.26% Fall from 52W High

SWOT Analysis

OneSource Specialty Pharma Live Price Chart